These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 24123108)

  • 1. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
    Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
    Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
    Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A
    Oncology; 2006; 70(6):411-7. PubMed ID: 17220639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?
    Raderer M; Chott A; Drach J; Montalban C; Dragosics B; Jäger U; Püspök A; Osterreicher C; Zielinski CC
    Ann Oncol; 2002 Jul; 13(7):1094-8. PubMed ID: 12176789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Japanese population.
    Ogusa E; Tomita N; Ishii Y; Takasaki H; Hattori Y; Matsumoto C; Ishigatsubo Y
    Hematol Oncol; 2013 Mar; 31(1):18-21. PubMed ID: 22278757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
    Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
    J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
    Kiesewetter B; Mayerhoefer ME; Lukas J; Zielinski CC; Müllauer L; Raderer M
    Ann Hematol; 2014 Feb; 93(2):249-53. PubMed ID: 23925930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
    Wöhrer S; Bartsch R; Hejna M; Drach J; Raderer M
    Scand J Gastroenterol; 2005 Oct; 40(10):1222-5. PubMed ID: 16265779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
    Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
    Levitt MJ; Gharibo M; Strair R; Schaar D; Rubin A; Bertino JR
    J Chemother; 2009 Aug; 21(4):434-8. PubMed ID: 19622463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
    Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Yoon DH; Yang DH; Lee WS; Kim HJ; Yhim HY; Jeong SH; Won JH; Lee S; Kong JH; Lim SN; Ji JH; Kwon KA; Lee GW; Lee JH; Lee HS; Shin HJ; Suh C
    Cancer Commun (Lond); 2019 Oct; 39(1):58. PubMed ID: 31619290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and therapeutic management of gastric lymphomas].
    Grau E; Perella M; Gómez A; Pastor E; Mirabet MD; García F; Ibáñez JL; Aguiló J
    Sangre (Barc); 1996 Apr; 41(2):109-14. PubMed ID: 9045350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
    Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M
    Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy is an effective first line treatment for early stage gastric mucosa-associated lymphoid tissue lymphoma.
    Yoon SS; Hochberg EP
    Cancer Treat Rev; 2006 Apr; 32(2):139-43. PubMed ID: 16524666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.